Explore ABL1/ABL gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Introcelluar Protein.
This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
| Target ID |
GM-T63505
|
| Target Name |
ABL1/ABL
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
25
|
| Gene ID |
100069715 (Equus caballus), 101087622 (Felis catus), 11350 (Mus musculus), 25 (Homo sapiens) 311860 (Rattus norvegicus), 491292 (Canis lupus familiaris), 540876 (Bos taurus), 722449 (Macaca mulatta)
|
| Target Alternative Names |
ABL,ABL1,Abelson murine leukemia viral oncogene homolog 1,Abelson tyrosine-protein kinase 1,Abl,Abl1,BCR-ABL,CHDSKM,E430008G22Rik,JTK7,Proto-oncogene c-Abl,Tyrosine-protein kinase ABL1,bcr/abl,c-ABL,c-ABL1,c-Abl,p150,v-abl
|
| Uniprot Accession |
P00520,P00519
|
| Protein Sub-location |
Introcelluar Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
ErbB signaling pathway, Ras signaling pathway, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Chronic myeloid leukemia, Viral myocarditis
|
| Gene Ensembl |
ENSECAG00000014981, ENSMUSG00000026842, ENSG00000097007, ENSCAFG00845020595, ENSBTAG00000017976, ENSMMUG00000012499
|
| Target Classification |
Kinase, Tumor-associated antigen (TAA)
|
Pre-made viral vector of ABL1/ABL cDNA Clones/ORF Plasmid
ABL1/ABL siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo25 | Pre-made Human ABL1/ABL/JTK7 siRNA oligo Duplex | 25 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo311860 | Pre-made Rat Abl1/Abl siRNA oligo Duplex | 311860 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo11350 | Pre-made Mouse Abl1/Abl/c-Abl siRNA oligo Duplex | 11350 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo722449 | Pre-made Cynomolgus/Rhesus macaque ABL1 siRNA oligo Duplex | 722449 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101087622 | Pre-made Cat/Feline ABL1 siRNA oligo Duplex | 101087622 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo491292 | Pre-made Dog/Canine ABL1 siRNA oligo Duplex | 491292 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo540876 | Pre-made Bovines/Cattle ABL1 siRNA oligo Duplex | 540876 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100069715 | Pre-made Equine/Horse ABL1 siRNA oligo Duplex | 100069715 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
ABL1/ABL antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T63505-Ab | Human | Anti-Human ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-rg-T63505-Ab | Rat | Anti-Rat ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-mg-T63505-Ab | Mouse | Anti-Mouse ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T63505-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-felg-T63505-Ab | Cat/Feline | Anti-Cat/Feline ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cang-T63505-Ab | Dog/Canine | Anti-Dog/Canine ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T63505-Ab | Bovines/Cattle | Anti-Bovines/Cattle ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-equg-T63505-Ab | Equine/Horse | Anti-Equine/Horse ABL1/ABL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
ABL1/ABL recombinant protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T63505-Ag | Human | Human ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-rg-T63505-Ag | Rat | Rat ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-mg-T63505-Ag | Mouse | Mouse ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-cynog-T63505-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-felg-T63505-Ag | Cat/Feline | Cat/Feline ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-cang-T63505-Ag | Dog/Canine | Dog/Canine ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-bovg-T63505-Ag | Bovines/Cattle | Bovines/Cattle ABL1/ABL recombinant protein | Mammalian cell | Detail |
| GM-Tg-equg-T63505-Ag | Equine/Horse | Equine/Horse ABL1/ABL recombinant protein | Mammalian cell | Detail |